AZD0156: Targeting ATM Kinase to Unveil Metabolic Vulnera...

2025-09-23

AZD0156 is a potent, selective ATM kinase inhibitor advancing cancer therapy research by modulating DNA damage response and uncovering metabolic vulnerabilities in tumor cells. This article explores the mechanistic nuances of AZD0156, its role in checkpoint control modulation, and its implications for combinatorial strategies in cancer research.

Plerixafor (AMD3100): Research Applications in CXCR4-Medi...

2025-09-22

This article explores the scientific utility of Plerixafor (AMD3100), a CXCR4 chemokine receptor antagonist, with a focus on it

WAY 629 hydrochloride

2025-09-19

MLN4924: Selective NAE Inhibitor Illuminates Neddylation ...

2025-09-19

Explore the mechanistic

TRV-7019

2025-09-18

SM-164: Advancing IAP Antagonist Strategies in Cancer Res...

2025-09-18

Explore how SM-164, a bivalent Smac mimetic and potent IAP antagonist for cancer therapy, enables rigorous investigation of apoptosis induction in tumor cells and caspase signaling pathways, offering new insights for translational cancer research.

FGFR-IN-1

2025-09-17

GBR 13069 dihydrochloride

2025-09-17

CVT 10216

2025-09-16

SDZ NKT 343

2025-09-16

SWTX-143

2025-09-15

DS89002333

2025-09-13

HPi1

2025-09-12

Anti-CD166 Rabbit Monoclonal Antibody

2025-09-11

Mesoridazine Besylate

2025-09-11